Detalhe da pesquisa
1.
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
Blood
; 142(24): 2105-2118, 2023 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562003
2.
Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.
J Allergy Clin Immunol
; 153(1): 287-296, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37793572
3.
Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia.
Clin Immunol
; 261: 109942, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38367737
4.
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
Lancet
; 402(10396): 129-140, 2023 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352885
5.
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC.
Blood
; 140(7): 685-705, 2022 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35671392
6.
Dermatologic complications in pediatric patients after hematopoietic stem cell transplantation for sickle cell disease.
Pediatr Dermatol
; 41(1): 61-65, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965881
7.
Risk factors for severe acute kidney injury after pediatric hematopoietic cell transplantation.
Pediatr Nephrol
; 38(4): 1365-1372, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125547
8.
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
Blood
; 135(23): 2094-2105, 2020 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268350
9.
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.
Blood
; 133(7): 754-762, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545834
10.
Hematopoietic Stem Cell Transplantation for Shwachman-Diamond Syndrome.
Biol Blood Marrow Transplant
; 26(8): 1446-1451, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32428734
11.
Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network.
Biol Blood Marrow Transplant
; 26(5): e94-e100, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32035274
12.
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(7): 1332-1341, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32234377
13.
Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
J Clin Immunol
; 40(8): 1211-1213, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32860171
14.
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.
Blood
; 132(13): 1438-1451, 2018 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997222
15.
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
Blood
; 132(17): 1737-1749, 2018 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30154114
16.
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy Consortium.
Pediatr Blood Cancer
; 67(10): e28444, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32776425
17.
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
J Clin Immunol
; 39(7): 653-667, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31376032
18.
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
Blood
; 130(25): 2718-2727, 2017 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29021228
19.
Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 24(5): 956-963, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29274396
20.
Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium.
Biol Blood Marrow Transplant
; 24(8): 1651-1656, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29753157